Stay up-to-date and never miss a thing.

PELOBiotech is attending 55th Annual Conference of the German Society for Mass Spectrometry (DGMS) at Technical University of Munich, Freising from ...

With the festive season just around the corner, we wish you and your loved ones a peaceful holiday season and time ...

1. Why a good Cell Culture practice is vital for the reproducibility of in vitro research

Cell culture experiments hold ...

... in Rotterdam.

PELOBiotech is attending Extracellular Vesicles and Nanoparticle Based Therapeutics Europe 2023 conference at the Hilton Rotterdam, ...

Embark on a journey through the world of cryopreservation, where life stands still in subzero temperatures. Explore accidental discoveries, the slow-freeze vs. vitrification debate, and the critical role of cryoprotective agents in preserving life. Join us in this chilly adventure today!

Unlocking the Future of Drug Development: Discover the Revolutionary Potential of Organ-on-a-Chip Technologies. Explore how the convergence of microfluidics and organoids is revolutionizing preclinical testing, offering enhanced predictability, reduced costs, and personalized medicine. Learn how these miniature organs-on-a-chip are transforming the pharmaceutical industry and paving the way for safer, more efficient drug discovery. Dive into the exciting possibilities and advancements in this cutting-edge field that holds the key to faster, more reliable, and animal-free drug development.

Amyloidosis is a group of disorders characterized by the extracellular deposition of misfolded proteins, forming insoluble amyloid fibrils. Despite significant advances in understanding the pathogenesis and treatment of amyloidosis, its diagnosis remains a challenge. This article aims to highlight the complexities involved in diagnosing amyloidosis, emphasizing the importance of early detection for improved patient outcomes.